← Back to feedRead original →
VERIFIEDET Finance·neutral
Nestle looks to develop new products to serve users of weight-loss drugs
AI Summary
- ·Nestle is developing specialized products for users of GLP-1 weight-loss drugs.
- ·Artificial intelligence is being used to analyze research and identify nutrient combinations for these products.
- ·The new offerings aim to address side effects such as muscle loss and facial fat, and manage post-treatment appetite increases.